ZYMUTEST HIA, IgGAM Screening

Description

Enzyme immuno-assay designed for measuring globally all heparin- dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma or serum, or in any biological fluid where these antibodies must be measured. This assay is proposed as screening, as an early identification of heparin treated patients presenting a risk to develop HIT or HITT. This assay measures the whole of antibodies. It offers the highest sensitivity as all isotypes are detected. It is the preferred assay when an early detection of heparin dependent antibodies is required for assessing the development risk of HIT/HITT.

Intended use

• Assessment of the risk to develop HIT/HITT, in patients treated with heparins (unfractionated or LMWH): presence of antibodies is a risk indicator for development of HIT/HITT.
• Clinical suspicion of HIT during heparin therapy.